Company Overview of Afraxis, Inc.
Afraxis, Inc., a drug discovery platform company, engages in developing central nervous system pharmaceutical screening technologies to evaluate pre-clinical therapeutics for the treatment of neurological and psychiatric disorders. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. Afraxis, Inc. was founded in 2007 and is based in La Jolla, California.
11099 N Torrey Pines Road
La Jolla, CA 92037
Founded in 2007
Key Executives for Afraxis, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Afraxis, Inc., please visit www.afraxis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.